Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single‑dose study of topical M707102 in healthy male subjects
jRCT2071230090Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in actinic keratosis (AK) comparing Topical M707102 with Topical M707102 vehicle (2 arms). Primary endpoints: Safety and Pharmacokinetics. Started Feb 2024; status: completed.
02
Drugs
M707102
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on jRCT2071230090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230090.